Vasospastic angina in a chronic myeloid leukemia patient treated with nilotinib.

Shunsuke MarutaKyohei UsamiKazuko TajiriMasafumi OtaniDaigo HirayaHiroaki WatabeTomoya HoshiAkira SatoMasaki Ieda

Published in: Cardio-oncology (London, England) (2021)

This case report highlights the potential vasculotoxic effects of nilotinib. Cardiologists and hematologists should be vigilant for coronary artery spasm as a possible vascular adverse event caused by nilotinib.

Keyphrases

chronic myeloid leukemia
case report
coronary artery
pulmonary artery
coronary artery disease
emergency department
human health
newly diagnosed
pulmonary arterial hypertension
climate change